Robuta

https://www.fiercebiotech.com/research/freshly-funded-ifm-therapeutics-defines-emerging-target-for-fighting-inflammatory-disease Freshly funded IFM Therapeutics defines emerging target for fighting inflammatory disease | Fierce... Jul 30, 2018 - Just two weeks after hauling in a $31 million series A funding round to form a new subsidiary, Boston-based IFM Therapeutics is laying out a case for the... ifm therapeutics